Snabes Michael C 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Jan 27, 2012
Insider Transaction Report
Form 4
Snabes Michael C
Sr. VP of Clinical Affairs
Transactions
- Award
Employee Stock Option (right to buy)
2012-01-25+165,000→ 165,000 totalExercise: $0.68Exp: 2022-01-24→ Common Stock (165,000 underlying)
Holdings
- 0
Common Stock
Footnotes (1)
- [F1]This option vests with respect to 41,250 shares on each of January 25, 2013, January 25, 2014, January 25, 2015 and January 25, 2016.